Lunch Symposia

 
 
 
 

Date: Wednesday 16 October

Time: 1245 – 1355hrs (lunch provided in hall)

Venue: Theatrette, Exhibition Hall

Title: Nasal High Flow; Targeting Conditions or Symptoms?

Guest speakers: Dr. Gonzalo Hernández (Spain) and Dr. Nuttapol Rittayamai (Thailand)

This session will inform you on:
* The latest evidence for Nasal High Flow (NHF) therapy
* Evaluate the emerging and clinically significant applications for NHF therapy in a variety of clinical settings.

 
 
 

Date: Wednesday 16 October

Time: 1245 – 1355hrs (lunch provided in hall)

Venue: Theatrette, Exhibition Hall

Chair: Dr. Kenneth Chan (Singapore)

Speaker 1: Dr. Michael Niederman (USA)
Title: Current Toolbox for treating Multidrug Resistant Pathogens in the ICU: Focus on Nosocomial Pneumonia

Speaker 2: Dr. Ricard Ferrer (Spain)
Title: Nosocomial Pneumonia in Ventilated Patients: Ceftolozane/Tazobactam Versus Meropenem (ASPECT-NP Study)

MSD Satellite Symposium Short Synopsis:
During this one-hour satellite symposium, Dr. Michael Niederman will discuss the disease burden of selected multi-drug resistant pathogens, focusing on nosocomial pneumonia in intensive care units . The audience will gain insights into the limitations of current treatment options available from various perspectives. Dr. Ricard Ferrer will then describe the recent ASPECT-NP study in nosocomial pneumonia, first presenting the study design, inclusion/exclusion criteria, patient demographic data, and primary/secondary end point results, and then reviewing the mortality, clinical cure and microbiology response results.

 
 
 

Date: Thursday 17 October

Time: 1245 – 1355hrs (lunch provided in hall)

Venue: Theatrette, Exhibition Hall

Immune modulation therapy in sepsis - fact or fantasy?
Professor Anthony McLean (Australia)
Professor McLean is Professor of Intensive Care at Sydney Medical School and Head of the Department of Intensive Care at Nepean Hospital, Sydney, Australia.

An overview of novel antimicrobials in current development or recently registered.
Doctor David Grolman (Australia)
Doctor Grolman is the Medical Director for the Hospital division of Pfizer in Australia, New Zealand and Korea, based in Sydney, Australia.

Resistance is futile…?: Antimicrobial-resistant Gram-negative bacteria in ICU.
Doctor Dean Gopalan (South Africa)
Doctor Gopalan is the Head of the Department of Anaesthesiology and Critical Care at the Nelson R Mandela Hospital and the University of KwaZulu-Natal in Durban, South Africa.

Haematology and Oncology patients in the ICU: Managing invasive fungal infections.
Professor Samir Agrawal (UK)
Professor Agrawal is a Consultant Haematologist and Senior Lecturer at the Queen Mary University and St. Bartholomew’s Hospital in London, United Kingdom.


Breakfast Symposium

 
 

Do No Harm: Impacting pressure injuries and hospital acquired pneumonia with evidence based practices

Date: Wednesday 16 October

Time: 0715 – 0830 (Breakfast served at 0715hrs)

Venue: Meeting Room 220

Speakers: Ms Kathleen Vollman and Dr Michelle Barakat Johnson.